EMMALINE MAURITSON: Open Payments
NPI 1952041972 · SANTA MONICA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$422 in 11 payments from 11 companies in 2025. Trend: 2023 $383 · 2024 $796 · 2025 $422
Food & beverage: $422
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 1 | $120 |
| Octapharma USA, Inc. | 1 | $48 |
| ABBVIE INC. | 1 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $34 |
| Tempus AI, Inc | 1 | $32 |
| Daiichi Sankyo Inc. | 1 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| ARRAY BIOPHARMA INC | 1 | $29 |
| TerSera Therapeutics LLC | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $22 |
Products named: LORBRENA, ENHERTU, PANZYGA, UBRELVY, XT CDX, PLUVICTO, Quzyttir, KEYTRUDA.
Industry payments across CA — which companies pay providers there.
